Swiss drugmaker expects its China sales to overtake Europe
Related Posts
India's Patently Wise Decision
China data point to stabilising economy
China health reforms help global pharma groups despite price cuts
Novartis loses patent battle in Indian court
Actavis agrees to purchase Warner Chilcott for US$8.5b
Actavis agrees to purchase Warner Chilcott for US$8.5b
China considers faster cut in pollution
Direct HK-Manchester flights set to start
China approves imports of new US-developed GM crops
US drug maker to launch 5 new products in China
